Catalyst Wire Dossier Catalyst Wire Dossier

valoctocogene roxaparvovec (Roctavian)

valoctocogene roxaparvovec · BioMarin Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for valoctocogene roxaparvovec (Roctavian), covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A [Phase 3]

See pricing